Recent Research in Selective Cyclin-Dependent Kinase 4 Inhibitors for Anti-Cancer Treatment

被引：15

作者：

Liu, Ning ^{[1
]}

Fang, Hao ^{[1
]}

Li, Yanling ^{[2
]}

Xu, Wenfang ^{[1
]}

机构：

[1] Shandong Univ, Dept Med Chem, Sch Pharmaceut Sci, Jinan 250012, Shandong, Peoples R China

[2] Innermongolia Technol Univ, BaoTou Med Coll, Baotou 014020, Innermongolia, Peoples R China

来源：

CURRENT MEDICINAL CHEMISTRY | 2009年 / 16卷 / 36期

关键词：

Cell cycle; G1-phase; cyclin-dependent kinases; CDK4; tumor; selective inhibitors; anti-cancer agents; CELL-CYCLE; RETINOBLASTOMA PROTEIN; BIOLOGICAL-ACTIVITY; IN-VITRO; CRYSTAL-STRUCTURE; TYROSINE KINASES; CDK4; INHIBITORS; CANCER-CELLS; DRUG DESIGN; POTENT;

D O I：

10.2174/092986709789909611

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

It is well known that cyclins and cyclin-dependent kinases (CDKs) play essential roles in regulation of the cell cycle. In past two decades, the scientific researches suggest that the cyclin D1/ CDK4 complex is a key regulator of the transition through the G1 phase of the cell cycle. Moreover, deregulation of the cyclin D /CDK4 pathway has been identified in multiple tumor types. Thus, CDK4 is a genetically validated therapeutic target; hence, there has been a surge of interests in finding selective CDK4 inhibitors as anti-cancer agents. This review will give the recent progress in the studies of structure, functions of CDK4 and highly selective and potent CDK4 inhibitors.

引用

页码：4869 / 4888

页数：20

共 114 条

[1] Preparation of novel aza-1,7-annulated indoles and their conversion to potent indolocarbazole kinase inhibitors [J].

Al-awar, RS ;

Ray, JE ;

Hecker, KA ;

Joseph, S ;

Huang, JP ;

Shih, C ;

Brooks, HB ;

Spencer, CD ;

Watkins, SC ;

Schultz, RM ;

Considine, EL ;

Faul, MM ;

Sullivan, KA ;

Kolis, SP ;

Carr, MA ;

Zhang, FM .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (15) :3925-3928

[2] 1,7-Annulated indolocarbazoles as cyclin-dependent kinase inhibitors [J].

Al-Awar, RS ;

Ray, JE ;

Hecker, KA ;

Huang, JP ;

Waid, PP ;

Shih, CA ;

Brooks, HB ;

Spencer, CD ;

Watkins, SA ;

Patel, BR ;

Stamm, NB ;

Ogg, CA ;

Schultz, RM ;

Considine, EL ;

Faul, MM ;

Sullivan, KA ;

Kolis, SP ;

Grutsch, JL ;

Joseph, S .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (12) :3217-3220

[3] Cyclin D1 in breast cancer pathogenesis [J].

Arnold, A ;

Papanikolaou, A .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) :4215-4224

[4] Design, synthesis and biological activity of new CDK4-specific inhibitors, based on fascaplysin [J].

Aubry, C ;

Wilson, AJ ;

Jenkins, PR ;

Mahale, S ;

Chaudhuri, B ;

Maréchal, JD ;

Sutcliffe, MJ .

ORGANIC & BIOMOLECULAR CHEMISTRY, 2006, 4 (05) :787-801

[5] The design and synthesis of novel 3-[2-indol-1-yl-ethyl]-1-H-indole derivatives as selective inhibitors of CDK4 [J].

Aubry, C ;

Patel, A ;

Mahale, S ;

Chaudhuri, B ;

Maréchal, JD ;

Suteliffe, MJ ;

Jenkins, PR .

TETRAHEDRON LETTERS, 2005, 46 (09) :1423-1425

[6] Deregulation of the RB pathway in human testicular germ cell tumours [J].

Bartkova, J ;

Lukas, C ;

Sorensen, CS ;

Rajpert-De Meyts, E ;

Skakkebæk, NE ;

Lukas, J ;

Bartek, J .

JOURNAL OF PATHOLOGY, 2003, 200 (02) :149-156

[7]

Bartkova J, 1996, CANCER RES, V56, P5475

[8] Pyrido[2,3-d]pyrimidin-7-one inhibitors of cyclin-dependent kinases [J].

Barvian, M ;

Boschelli, DH ;

Cossrow, J ;

Dobrusin, E ;

Fattaey, A ;

Fritsch, A ;

Fry, D ;

Harvey, P ;

Keller, P ;

Garrett, M ;

La, F ;

Leopold, W ;

McNamara, D ;

Quin, M ;

Trumpp-Kallmeyer, S ;

Toogood, P ;

Wu, ZP ;

Zhang, EL .

JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (24) :4606-4616

[9] 2-Aminoquinazoline inhibitors of cyclin-dependent kinases [J].

Bathini, Y ;

Singh, I ;

Harvey, PJ ;

Keller, PR ;

Singh, R ;

Micetich, RG ;

Fry, DW ;

Dobrusin, EM ;

Toogood, PL .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (17) :3881-3885

[10] Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 1: Identification and optimisation of substituted 4,6-bis anilino pyrimidines [J].

Beattie, JF ;

Breault, GA ;

Ellston, RPA ;

Green, S ;

Jewsbury, PJ ;

Midgley, CJ ;

Naven, RT ;

Minshull, CA ;

Pauptit, RA ;

Tucker, JA ;

Pease, JE .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (18) :2955-2960

← 1 2 3 4 5 6 7 8 9 10 →